mounjaro tirzepatide approvazione italia Mounjaro: costa 300-500 € al mese. Quando è rimborsato FDA APPROVA TIRZEPATIDE, FARMACO ANTIOBESITA'

Fasting insulin, HbA1c, lipid panels, and inflammatory markers like hs-CRP can all shift meaningfully during treatment

Key Takeaways Different FDA Approvals : Wegovy is FDA-approved specifically for chronic weight management in adults with obesity (BMI 30) or weight-related conditions (BMI 27), while Ozempic is FDA-approved only for type 2 diabetes management

Red flags requiring dose reduction or stopping: Persistent vomiting or inability to keep fluids down

Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment